Yale Cancer Center/X
Dec 11, 2024, 00:01
Calcineurin Inhibitor plus Eltrombopag in reducing transfusion requirements
Yale Cancer Center shared a post on X:
“Jessica M. Stempel and Dr. Nikolai Podoltsev share research demonstrating that Calcineurin Inhibitor plus Eltrombopag is effective in reducing transfusion requirements for patients with acquired Aplastic Anemia.”
More posts featuring Yale Cancer Center.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 7, 2025, 04:00
Jan 6, 2025, 19:32
Jan 6, 2025, 19:23
Jan 6, 2025, 19:21
Jan 6, 2025, 19:13
Jan 6, 2025, 19:09
Jan 6, 2025, 17:15
Jan 6, 2025, 17:07
Jan 6, 2025, 16:37